Live symbol workspace

NASDAQ market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Status Chart ready

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for NASDAQ skewed neutral (204 of 465 scored calls). The most accurate provider on this asset is groq-llama-3.1-8b-instant at 41.0% across 444 verified calls.

Provider track record

groq-llama-3.1-8b-instant

182/444 verified calls

41.0%

Confidence trend

59%

▼ 0.4 pts vs previous week

Avg confidence across 50 calls in the last 7 days

What sources say

Neutral 204 articles

Celularity Receives Nasdaq Notice Regarding Form 10-Q

Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing

Deep Sea Minerals Announces Application to List on the Nasdaq Capital Market; Shares up 12%

Bullish 195 articles

S&P 500, Nasdaq, Dow Jones Touch Record Highs as Trump Close to Making Decision on Iran Peace Deal

Hyperliquid Is 'Bigger Than Nasdaq,' Says ICE CEO — HYPE Eyes New Record High, While ETFs Top $100M

Dan Ives: Anthropic’s growth is 'just the tip of the sphere' for AI rally

Bearish 66 articles

THE GROWHUB LIMITED Announces Receipt of Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency

Peter Schiff: MicroStrategy’s ‘Smart’ Debt Buyback Just Torched 60% of Its Safety Net

Nasdaq and Dow Jones called lower as US and Iran exchange fire over Hormuz

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

NASDAQ News Intelligence (3671 articles)

AI-curated news influencing NASDAQ price, sentiment, and trend

Explore All NASDAQ News with AI Analysis

Stocks

5 months, 2 weeks ago

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Dec. 16, 2025, the company approved non-statutory stock options to purchase …

Impact on NASDAQ: Market impact analysis based on neutral sentiment with 73% confidence.

PTC Therapeutics approved stock options and RSUs for five new employees, totaling 3,825 shares and … High (73%)

View full analysis →

Unknown 73% confidence

Stocks

5 months, 2 weeks ago

How major US stock indexes fared Friday, 12/19/2025

Stocks gained ground on Wall Street as AI stocks like Nvidia turned higher again. The S&P 500 rose 0.9% Friday, …

Impact on NASDAQ: Market impact analysis based on bullish sentiment with 78% confidence.

US stock indexes, including the S&P 500, Dow Jones, and Nasdaq, closed higher on Friday, … High (78%)

View full analysis →

Unknown 78% confidence

Stocks ⭐ FEATURED

5 months, 2 weeks ago

Stock market today: Dow, S&P 500, Nasdaq rise as Oracle, Nvidia lead AI trade resurgence

US stocks rose as 2025's last full week of trading drew to a close, with Wall Street weighing catch-up jobs …

Impact on NASDAQ: Market impact analysis based on bullish sentiment with 83% confidence.

US stocks, including the Dow, S&P 500, and Nasdaq, rose as the last full week … High (83%)

View full analysis →

Unknown 83% confidence

Stocks

5 months, 2 weeks ago

S&P 500 Gains 0.9% to Climb Out of This Week's Hole

The Nasdaq Composite rose 1.3%. A broad stock market rally lifted the major indexes as traders continued to buy in …

Impact on NASDAQ: Market impact analysis based on bullish sentiment with 83% confidence.

The S&P 500 and Nasdaq Composite indices experienced a positive week, with the S&P 500 … High (83%)

View full analysis →

Unknown 83% confidence

Stocks

5 months, 2 weeks ago

Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)

WAYNE, Pa., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing …

Impact on NASDAQ: Market impact analysis based on bullish sentiment with 75% confidence.

Aclaris Therapeutics has been added to the Nasdaq Biotechnology Index (NBI), a benchmark for biotech … High (75%)

View full analysis →

Unknown 75% confidence

Stocks

5 months, 2 weeks ago

Jim Cramer on Micron: “It Is One of My Absolute Favorite Stocks”

Micron Technology, Inc. (NASDAQ:MU) is one of the stocks Jim Cramer talked about recently. Cramer noted that storage stocks like …

Impact on NASDAQ: Market impact analysis based on bullish sentiment with 79% confidence.

Jim Cramer has expressed strong support for Micron Technology, highlighting the significant demand for storage … High (79%)

View full analysis →

Unknown 79% confidence